AstraZeneca will acquire Almirall's respiratory drug portfolio

AstraZeneca’s respiratory franchise is expected to see a significant boost with the assumption of Almirall’s pipeline of novel respiratory assets.



via Marketing - Latest News http://ift.tt/1ADrrSw